A little startup, Arbutus Medical, is killing it this year.
A quick update includes: Traction Growth, SwiftKit™ Launch Wins, and High-Impact 1099 Opportunities Across the Midwest
If you’ve followed my writings, you know Arbutus Medical is one of my favorite ortho startups.
They’re not just another device company — they’re systematically building the category of “Surgery Outside the OR™” with smart, procedure-specific sterile kits that eliminate the wasteful scavenger hunts and delays that plague emergency departments every single day.
The Arbutus momentum in 2026 has been outstanding.
TrakPak® Continues Its Dominant RunArbutus’ flagship TrakPak® (skeletal traction in one sterile kit with the innovative QuikBow® tension bow) is now in use at over 70 Level 1 trauma centers across the U.S. That’s a massive leap from the already impressive numbers we discussed earlier this year. Major names include Mayo Clinic, Cleveland Clinic, University of Chicago, Barnes-Jewish, R Adams Cowley Shock Trauma, and Harborview Medical Center (where it has become standard of care and where they’ve now trained 40+ residency programs).
Hospitals that once spent 45+ minutes (sometimes hours) gathering supplies are now ready in minutes with just TrakPak®, lidocaine, and gloves. The clinical and economic impact is real — and the adoption curve keeps accelerating.SwiftKit™ Enters the Chat — and Wins BigIn 2026 Arbutus launched the Finger Amputation SwiftKit™ (Digit Revision SwiftKit™), purpose-built for fingertip amputation and digit revision procedures in the ED. Early wins are already rolling in at high-volume centers including:
- Harborview Medical Center
- Wake Forest Baptist
- WellSpan York
- Carolinas Medical Center
This is exactly how Arbutus executes: identify a painful, inefficient bedside procedure, wrap everything into one sterile, ready-to-use kit, and let clinical teams move faster with better consistency.
The Arbutus Education Engine Running Hot
Over the past two months alone, Arbutus has trained or retrained more than 40 clinical teams at Level I Trauma Centers in cadaver and saw-bone labs covering both skeletal traction and fingertip amputation. This resident-led flywheel is one of the smartest parts of their go-to-market strategy — once a program standardizes, the residents train the next wave.
Arbutus Sales Expansion: Hybrid Model + 1099 Opportunities
With strong clinical proof and fresh capital from their oversubscribed C$9.3M growth round earlier this year, Arbutus is scaling the commercial team with a smart hybrid approach: dedicated internal Regional Sales Managers + experienced 1099 independent reps.They are actively recruiting sharp 1099 partners in several high-potential Midwest and nearby markets where the clinical need is clear and the beachhead is already forming.Top open territories right now (see territory map above):
- Detroit and neighboring markets (Ann Arbor & Grand Rapids)
- Chicago
- Minnesota (Minneapolis area)
- Milwaukee
- Kansas City
- Pittsburgh
These are exactly the kinds of markets where Arbutus products can quickly become standard of care — busy trauma centers, high ED volume, and teams hungry for efficiency tools that actually work.Attractive 1099 Compensation StructureArbutus has built a clean, front-loaded milestone payment model that aligns incentives perfectly:
- $500–$1,000 cash upfront for the introductory meeting
- $1,000–$10,000 on PO (range depends on account size)
- 5% of Year 1 revenue on top
- Clean break after Year 1 — no tail
Arbutus’ Attractive Milestone-Based Compensation
Arbutus offers a clean, tiered milestone payment structure for its TrakPak 1099 Representative Program that rewards front-loaded effort. Reps earn an upfront payment for the introductory meeting ($500 for small accounts, $750 for medium, or $1,000 for large), followed by a substantial payment upon PO receipt ($1,000 / $4,200 / $10,000 depending on account size), plus 5% of Year 1 revenue. There is no recurring commission tail beyond Year 1. Importantly, Arbutus handles all deal coordination, VAC processes, positioning, and long-term account management, so 1099 partners focus purely on opening doors to orthopedic teams and supporting the critical first 120 days of adoption and stock visibility. No case coverage or procedural presence is required.
The model recognizes that the rep’s highest-value work happens upfront: opening doors, introducing the clinical problem and solution, and supporting the first 120 days of adoption. Arbutus then owns the VAC process, contracting, and long-term account management. Pay matches the actual work — and the upside is real as accounts scale.
Help Build Arbutus in the Midwest
If you’re a proven 1099 ortho/trauma sales rep (or have strong ED/trauma relationships) in or near any of the territories shown on the map — Detroit/Ann Arbor/Grand Rapids, Chicago, Minneapolis, Milwaukee, Kansas City, or Pittsburgh — this is a genuine opportunity to get in early with a company that is executing at a high level and solving a real, painful problem for hospitals.
These 1099 roles will directly support Arbutus’ aggressive 2026–2028 growth plan and help scale the momentum we’re already seeing.I recently placed Josh Willett with the Arbutus team, and these new 1099 partners will play a key role in helping him and the broader sales organization win in these markets.
If you’re interested, email Josh directly at josh.willett@arbutusmedical.ca (mailto:josh.willett@arbutusmedical.ca) with:
- Your resume
- A short note on why these specific territories and Arbutus excite you (and any relevant trauma/ED relationships you bring)
Arbutus continues to be one of the cleanest, most exciting ortho stories I’ve seen in years — strong clinical data, real hospital ROI, lean execution, and now the capital and team to scale.
The Midwest expansion is the next chapter, and I’m excited to help the right reps get in on it.
Let’s go.
— Tiger